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ABSTRACT Measurement of live-cell binding interactions is vital for understanding the biochemical reactions that drive cellular
processes. Here, we develop, characterize, and apply a new procedure to extract information about binding to an immobile
substrate from ﬂuorescence correlation spectroscopy (FCS) autocorrelation data. We show that existing methods for analyzing
such data by two-component diffusion ﬁts can produce inaccurate estimates of diffusion constants and bound fractions, or even
fail altogether to ﬁt FCS binding data. By analyzing live-cell FCS measurements, we show that our new model can satisfactorily
account for the binding interactions introduced by attaching a DNA binding domain to the dimerization domain derived from a site-
speciﬁc transcription factor (the vitellogenin binding protein (VBP)). We ﬁnd that our FCS estimates are quantitatively consistent
with our ﬂuorescence recovery after photobleaching (FRAP) measurements on the same VBP domains. However, due to the fast
binding interactions introduced by the DNA binding domain, FCS generates independent estimates for the diffusion constant (6.7
5 2.4 mm2/s) and the association (25 1.2 s1) and dissociation (195 7 s1) rates, whereas FRAP produces only a single, but
a consistent, estimate, the effective-diffusion constant (4.45 1.4 mm2/s), which depends on all three parameters. We apply this
new FCS method to evaluate the efﬁcacy of a potential anticancer drug that inhibits DNA binding of VBP in vitro and ﬁnd that
in vivo the drug inhibits DNA binding in only a subset of cells. In sum, we provide a straightforward approach to directly measure
binding rates from FCS data.INTRODUCTION
Recent advances in light microscopy have made it possible
to probe molecular interactions within live cells (1). One
important assay is the measurement of in vivo association
and dissociation rates (2). These rates may differ consider-
ably from their in vitro counterparts. For example, transcrip-
tion factors are bound much more transiently in vivo (3,4)
(on the order of seconds) than expected from in vitro
measurements (on the order of minutes to hours). The
in vivo observations have now generated a much more
dynamic picture of transcription complex assembly (5). In
addition to providing new insights into cellular function,
measurements of in vivo binding rates also provide the raw
materials for accurate mathematical modeling of cellular
processes, a central goal of systems biology (6).
One technique for measuring in vivo association and disso-
ciation rates is fluorescence recovery after photobleaching
(FRAP) (7,8). In this procedure, a region of interest within
a cell is irreversibly photobleached, and then the rate at which
fluorescence recovers within the region is quantified. The
recovery curve is fit using amathematical model that incorpo-
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0006-3495/09/07/0337/10 $2.00rates diffusion and binding terms (9–12). In the best case, the
fitted parameters provide independent estimates of the free-
diffusion constant and the association and dissociation rates,
although under less optimal conditions only ratios of some
of these parameters can be estimated (12).
FRAP is well suited for measuring the association and
dissociation rates of moderately fast binding interactions,
namely those that give rise to recoveries that range from
a few seconds to a few minutes. This timescale is easily
measured on standard confocal microscopes, which are
now widely used to perform FRAP. However, faster binding
interactions that produce very rapid recoveries on the order
of a second or less are more difficult to measure by FRAP.
Even when recovery curves can be measured, such fast inter-
actions frequently restrict the FRAP estimate to an effective
diffusion constant, which only indirectly captures the retar-
dation due to binding (9).
Rapidmolecular dynamics have traditionally been analyzed
by an alternate approach better suited to these kinetics, namely
fluorescence correlation spectroscopy (FCS) (13). In FCS, the
fluctuations in the concentration of a fluorescent molecule
within a small femtoliter volume are used to compute an auto-
correlation function, which is then usually fit with a model for
diffusion. Binding interactions can be detected if the labeled
molecule binds to a much larger molecule that diffuses signif-
icantly more slowly than does the free, labeled molecule.
When this occurs, the FCS data will be well fit by a model
with two diffusing components (14). The fractions of the fast
doi: 10.1016/j.bpj.2009.04.027
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and bound molecules. This FCS approach has been widely
used in live cells to estimate the fraction of bound molecules
(15–18), but unfortunately it does not provide estimates of
association and dissociation rates, and furthermore is not
strictly applicable to immobile binding sites.
Here, we derive and apply an FCS model for diffusion and
binding that can be used to estimate association and dissocia-
tion rates at immobile binding sites within live cells directly
from an FCS autocorrelation function. We apply the model
to the dimerization and binding domains derived from
the transcription factor vitellogenin binding protein (VBP),
which is one member of the large and important family of
leucine-zipper transcription factors (19). Using the dimeriza-
tion and binding domains of VBP, we estimate in live cells
its association and dissociation rates of binding to chromatin.
We analyze kinetics of the samemolecule by FRAP, obtaining
results quantitatively consistent with the FCS predictions.
However, due to the rapid binding interactions of VBP with
chromatin, the FRAP estimate provides only an effective-
diffusion constant and thus no direct estimate of association
and dissociation rates. Thus, our analysis demonstrates the
feasibility and advantages of estimating association and disso-
ciation rates of fast binding interactions directly fromFCSdata.
THEORY
Full model
We consider a molecule that diffuses with diffusion constant
Df and binds to an immobile substrate with association and
dissociation rates kon and koff. d f ð~r; tÞ and dcð~r; tÞ are
the fluctuations in the concentrations of free and bound
molecules, respectively. If a large pool of free binding sites
exists, the appropriate diffusion and binding equations are
(see Supporting Material)
vdf
vt
¼ DfV2d f  kondf þ koffdc
vdc
vt
¼ kond f  koffdc :
(1)
These equations have been extensively studied in the FRAP
literature (9,10,12,20). They are a specific case of the gener-
alized diffusion-and-binding system for FCS first considered
by Elson and Magde, and later by Aragon and Pecora (21)
and Krichevksy and Bonnet (22). All of these FCS analyses
used Fourier transforms to solve for the general case of m
diffusing species, each reacting with the remaining m  1
components (23).
The Elson and Magde theory was based on a cosine illu-
mination pattern in z, which was later adapted by Krichevsky
and Bonnet (22) to a Gaussian z profile, an illumination
pattern that is more appropriate for current confocal and
two-photon FCS instruments. Thus, for our derivation of
the specific autocorrelation function corresponding to Eq. 1
above, we used the Bonnet solution, with the number ofBiophysical Journal 97(1) 337–346chemical components set to two and the diffusion constant
for the bound species set to zero. As shown in the Supporting
Material, this yields the autocorrelation function, G(t), which
we call the full model for diffusion and binding:
GðtÞ ¼ w
2
xywz
8Nð2pmÞ3=2
Z
Gð~qÞUð~q; tÞd3~q; (2)
where N is the number of fluorescent molecules in the obser-
vation volume, m ¼ 1,2 for one- or two-photon excitation,
respectively, wxy and wz are the width and height of the
observation volume, which can be measured using standard
procedures (see Supporting Material), and~q ¼ ðqx; qy; qzÞ is
the Fourier transform variable. The term Gð~qÞ accounts for
the illumination profile:
Gð~qÞ ¼ e

w2xy
4m
ðq2x þ q2yÞ 
w2z
4m
q2z
; (3)
and the term Uð~q; tÞ accounts for the diffusion and chemical
kinetics:
Uð~q; tÞ ¼ 1
2

el1tð1 fÞ þ el2tð1 þ fÞ; (4)
with l values given by
l1 ¼ 1
2
 q2Df  koff  kon  ﬃﬃﬃap 
l2 ¼ 1
2
 q2Df  koff  kon þ ﬃﬃﬃap  ; (5)
and f given by
f ¼ k

on þ koffﬃﬃﬃ
a
p þ k

on  koff
kon þ koff
q2Dfﬃﬃﬃ
a
p ; (6)
where q2 ¼ q2x þ q2y þ q2z and a ¼ ðq2Df þ kon þ koffÞ2
4q2Dfkoff .
The full model solution (Eq. 2) thus depends on four
unknown parameters,Df, k

on, koff, and N, which can be deter-
mined by fitting to experimental data.
As a check, we compared a 2D (xy) version of Eq. 2 to the
2D ‘‘stick and diffuse’’ model recently derived to account for
the binding of endocytotic vesicles to an immobile
membrane scaffold (24). The derivation of the ‘‘stick and
diffuse’’ model was not based on chemical kinetics, but
rather on the probabilities of adhering to and diffusing on
a 2D surface. We found that the 2D version of our diffu-
sion-and-binding model agreed with the ‘‘stick and diffuse’’
model for a wide range of kon, koff, and Df values (data not
shown), reinforcing the validity of both approaches.
Simpliﬁed regimes
Our diffusion-and-binding model (Eq. 2) should be capable
of fitting all possible autocorrelation functions that could
arise by the binding of a diffusing molecule to an immobile
substrate. However, in FRAP, the comparable full-model
solution reduces under different conditions to four simpler
DNA Binding Probed by FCS 339equations, which in all but one case impose restrictions on
the parameters that can be estimated (12). In the Results
section, we present a comparable analysis for FCS.
The four simplified equations describe the pure-diffusion,
effective-diffusion, hybrid-model, and reaction-dominant
regimes. The derivations for each of these regimes are given
in the Supporting Material. Table 1 summarizes this analysis
by providing for each regime the simplified autocorrelation
function that describes it and the parameters that can be esti-
mated when FCS data lie in that regime. The validity of the
full diffusion-and-binding model and its simplified regimes
was confirmed by fitting Monte Carlo simulated data sets
(see Fig. S1 in Supporting Material).
METHODS
Cell culture and transient transfection of GFP-tagged constructs were
performed as previously described by Mueller et al. (25) (for details, see
Supporting Material).
Experimental FCS and FRAP protocol
FCS experiments were performed with a two-photon FCS system (see Sup-
porting Material). We calibrated the two-photon excitation volume before
each experiment by measuring the diffusion coefficients of Alexa 488
(Invitrogen, Carlsbad, CA) and enhanced green fluorescent protein (eGFP)
(Biovision, Mountain View, CA) using a wavelength of 970 nm, which
resulted in volume dimensions of wxy ¼ 0.35 mm and wz ¼ 1.5 mm.
Cells were kept at 37C on the microscope stage using an objective heater
(Bioptechs, Butler, PA). To identify a suitable spot for acquiring FCS data,
we acquired two-photon images of the entire cell. Regions were selected that
occupied a central section of the nucleus far from both the nuclear envelope
and nucleoli. We set the laser excitation power at <8 mW at the microscope
entrance to avoid excitation saturation effects and to minimize photobleach-
ing. We acquired FCS data for 10–20 s, and repeated each measurement five
times at the same location. These data were averaged and then fit, producing
estimates for that location, before moving to another spot in the same cell.
Two or three different locations per nucleus were chosen, and at least 15
averaged curves were analyzed per sample. We rejected data with artifacts
due to either visible photobleaching (gradual decay of the fluorescence
intensity) or cell mobility (a sudden variation in the photon counts).
FRAP experiments were carried out as described by Mueller et al. (25)
(for details see Supporting Material).FCS data analysis
The reaction-diffusion models used are described in the Theory section and
Table 1. In addition, we also fit some data with a two-component diffusion
model (14):
GðtÞ ¼ 1
23=2N
"
r

1 þ t
tD1
1
1 þ t
u2tD1
1=2
þ ð1 rÞ

1 þ t
tD2
1
1 þ t
u2tD2
1=2#
;
(7)
where D1 are D2 are the diffusion constants of the two species, which are
presumed to be of equal brightness, r and 1  r are the fractions of mole-
cules diffusing at rates D1 and D2, and u is defined in Table 1.
Analysis of FCS data was performed with routines written in Matlab (The
MathWorks, Natick, MA). For each time point ti, the average y(ti) of the five
autocorrelation functions obtained at a single location was calculated,
together with its standard deviation s(ti). The averaged single-spot data
were then fit to the full reaction-diffusion model (Eq. 2) and also to each
of the simplified-regime models (Table 1). We used numerical integration
to compute both the full and the hybrid models. All other models were given
by closed-form solutions. In all cases, we used the nlinfit routine to minimize
the quantity c2, defined as
c2 ¼
X
i
	
yfðtiÞ  yðtiÞ
sðtiÞ

2
; (8)
where yf represents the fitted function. This fit then yielded estimated param-
eters for that location. Estimated parameters for other locations in that cell or
for other cells were then averaged together to provide mean values and stan-
dard deviations.
To select which model was more appropriate to describe the experimental
data, we performed F-tests at the 95% confidence level, based on the reduced
c2v ¼ c2=ðv p 1Þ (26).
RESULTS
Analysis of the FCS diffusion-and-binding model
To determine when restrictions on parameter estimation
would arise in the FCS diffusion-and-binding model, we
compared the full-model solution (Eq. 2) to the solutions
for each of the simplified models (Table 1). By performingTABLE 1 Autocorrelation functions and measurable parameters for the four FCS simpliﬁed regimes
Regime name Conditions Autocorrelation function Measurable parameters
Pure diffusion kon  koff GDðtÞ ¼
1
23=2N

1þ t
tDf
1
1þ t
u2tDf
1=2
where tD ¼ w2xy=4mDf and u ¼ wz/wxy Df
Effective diffusion tD[1=k

on GEDðtÞ¼
1
23=2N

1þ t
tDeff
1
1þ t
u2tDeff
1=2
where tDeff ¼ w2xy=4mDeff and u ¼ wz/wxy Deff ¼ Df=ð1þ kon=koffÞ
Hybrid model kon[koff GðtÞ ¼
w2xywz
8Nð2pmÞ3=2
Z
Gð q!Þ expðlHtÞd3 q! where lH ¼ ðq
2Df=k

onÞkoff
1þ q2Df=kon
Df=k

on and koff
Reaction dominant tD  1=kon GðtÞ ¼ FeqGDðtÞ þ
1
23=2N
Ceqe
koff t where Feq ¼ koff
koff þ kon
and Ceq ¼ k

on
koff þ kon
Df, k

on and koff
Variables are defined in theTheory section. ‘‘Conditions’’ describewhen the simplified regime is a good approximation to the fullmodel.When the bound fraction
is either low or high, the pure-diffusion or the hybrid model, respectively, is a good approximation. When the time to diffuse through the illumination volume is
either much longer or much shorter than the time to associate with a binding site, the effective-diffusion or the reaction-dominant model, respectively, is a good
approximation. As shown under ‘‘Measurable parameters’’, the reaction-dominant regime is the only simplified regime in which the diffusion constant, associ-
ation anddissociation rates can be determined independently. (Note that ‘‘reaction-dominant’’ aswedefine it for FCS includes both a diffusive phase and a binding
phase, unlike in our original definition for FRAP (12). We extend the FRAP formula for the reaction-dominant model in the Supporting Material).Biophysical Journal 97(1) 337–346
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ciation (koff) rates, we generated a regime space that defines
when the simplified formulas are accurate approximations to
the full model (Fig. 1 A).
To define what parts of this regime space would yield
decay times easily measured in FCS experiments, we varied
kon and koff and calculated the corresponding decay time of
the autocorrelation function. We found that any of the simpli-
fied regimes could yield decay times of a few seconds (Fig. 1
B), which is a practical upper bound on typical FCS measure-
ments (27). Thus, any of the four simplified regimes could be
expected to arise in FCSmeasurements on biological samples.
This means that it is important to test whether a simplified
regime can fit experimental data, since several of the simpli-
fied regimes impose restrictions on what parameters can
be estimated. If the one-component diffusion model fits the
data, then only one parameter can be determined: the ratio
Df=ð1þ kon=koffÞ. If the hybrid model fits the data, then
two parameters can be determined: koff and the ratio
Df=k

on. (Note that in either of these cases, more information
can be obtained if the free-diffusion constant (Df) can be esti-
mated independently). If the reaction-dominant model fits
the data, then all three parameters, Df, k

on, and koff, can be
determined independently. If none of the simplified models
fits the data, but the full model fits, then all three parameters
can be determined independently.
Application of the FCS diffusion-and-binding
model to domains derived from the transcription
factor VBP
FCS measurements were made using a custom two-photon
microscope equipped with a correlator board. Using this
instrument, the signal intensity of the eGFP constructs exam-
ined here remained constant over the period of data acquisi-
tion, suggesting minimal photobleaching. FCS data were
obtained from individual cells and then fit to yield single-
cell parameter estimates, which were then averaged over
many cells. All of the figures in this article show examples
of single-cell fits, and Table 2 contains the averaged para-
meter estimates from many such fits.
As a control, we first performed FCS measurements
on unconjugated eGFP in nuclei (Fig. 2 A). Both FCS
(Fig. 2 B) and FRAP (Fig. 2 C) data on single cells were well
fit by a one-component diffusion model. The estimated diffu-
sion constants from these two independent measurements
were within error (Table 2) and also consistent with published
estimates fromother cells (16,17,28). These results suggest that
our conditions for live-cell FCS and FRAP were appropriate.
To evaluate the diffusion-and-binding model, we then per-
formed FCS on two related molecules, only one of which was
expected to bind DNA, because only it contained a DNA
binding domain. The two molecules were both derived from
the transcription factor VBP. VBP is a member of the basic
leucine zipper family of transcription factors, which containBiophysical Journal 97(1) 337–346a basic domain responsible for DNA binding and a ‘‘leucine
zipper’’ domain required for dimerization (Fig. 3 A) (19).
One of themoleculeswe examined (VBP-L-ZIP) contained
only the leucine zipper (Fig. 3B). Thismolecule dimerizes but
does not bind to DNA in vitro (29). Consistent with this,
in vivo single-cell autocorrelation functions for VBP-L-ZIP
were well fit by a one-component diffusion model (Fig. 3 D).
The average diffusion constant (135 4 mm2/s (Table 2)) was
consistent with free diffusion of VBP-L-ZIP, as predicted
from its estimated hydrodynamic radius (see Supporting
Material for an overview of this calculation).
A
B
FIGURE 1 (A) The idealized regimes are combined to generate a regime
space showing where each idealized model is a reasonable approximation to
the full model (sum of residuals between full and idealized models <1).
When constructing this composite regime space, overlaps between idealized
regimes were resolved by selecting the idealized model with the fewest
number of parameters. The details of the calculation of the regime space
and a plot for each simplified model are provided in the Supporting Material
(Fig. S2, A–E). (B) To determine which regimes could impact typical FCS
measurements, we computed the time at which the autocorrelation function
drops to 1% of its initial value (gray lines). Note that all regimes are encoun-
tered on typical FCS timescales of 0.1–10 s. This regime space was calcu-
lated for a cellular diffusion constant of 10 mm2/s, close to the theoretically
predicted value for VBP-B-ZIP.
DNA Binding Probed by FCS 341The other molecule we examined (VBP-B-ZIP) contained
both the leucine zipper and the basic region that binds to
DNA in vitro (29). Consistent with this, the in vivo VBP-
B-ZIP FCS data were not well fit by a one-component diffu-
sion model (Fig. 3 E), whereas the full diffusion-and-binding
model yielded good fits (Fig. 3 F). To determine whether
these fits could reliably estimate Df, k

on, and koff, we tested
whether the VBP-B-ZIP data could be fit with any of the
simplified models, and found that only the reaction-dominant
model yielded a good fit, indicating that independent esti-
mates of Df, k

on, and koff are possible (Table 1). The esti-
mated VBP-B-ZIP diffusion constant (6.7 5 2.4 mm2/s
(Table 2)) is consistent with its predicted free-diffusion
constant based on the hydrodynamic radius of VBP-B-ZIP
(see Supporting Material). The predicted association and
dissociation rates of binding (Table 2) suggest transient inter-
actions with chromatin with an association time of ~500 ms
(1=kon) and a residence time of ~50 ms (1/koff).
In sum, the VBP-L-ZIP and VBP-B-ZIP domains provide
a simple test of the diffusion-and-binding model. Without
the DNA binding domain, a one-component diffusion model
suffices to explain the FCS data (VBP-L-ZIP). With the DNA
binding domain, the one-component diffusion model fails,
and a diffusion-and-binding model is now required to yield
a good fit to the FCS data (VBP-B-ZIP).
Comparison of the diffusion-and-binding model
to the two-component diffusion model
As noted in the Introduction, previous FCS analyses of
binding interactions within live cells have typically employed
two-component diffusion fits. We found that the VBP-B-ZIP
TABLE 2 Estimated parameters with standard deviations
obtained from FCS or FRAP ﬁts
Estimated parameters
Molecule FCS FRAP
eGFP Df ¼ 23 5 7 mm2/s Df ¼ 26 5 5 mm2/s
VBP-L-ZIP Df ¼ 13 5 4 mm2/s Df ¼ 14 5 4 mm2/s
VBP-L-ZIP þ drug Df ¼ 11 5 3 mm2/s Not measured
VBP-B-ZIP Df ¼ 6.7 5 2.4 mm2/s,
kon ¼ 251:2 s1,
koff ¼ 195 7 s1
Deff ¼ 4.4 5 1.4 mm2/s
VBP-B-ZIP þ drug
(~60% of cells)
Df ¼ 5.6 5 1.9 mm2/s Not measured
VBP-B-ZIP þ drug
(~40% of cells)
Df ¼ 4.4 5 1.5 mm2/s,
kon ¼ 2:652:8 s1,
koff ¼ 185 17 s1
Not measured
The values forDf for eGFP, VBP-L-ZIP, and VBP-B-ZIP are consistent with
the increasing sizes of these molecules. Furthermore, the FRAP and FCS
measurements yield consistent results for eGFP, VBP-L-ZIP, and VBP-B-
ZIP (for the latter, see the formula for Deff in Table 1). ‘‘þ drug’’ indicates
that the putative DNA binding inhibitor NSC13746 was added at a 100-mM
concentration. VBP-B-ZIP lacks a DNA binding domain, and so, as
expected, the drug has no detectable effect on the VBP-L-ZIP diffusion
constant. VBP-B-ZIP, which contains a DNA binding domain, shows inhi-
bition of DNA binding in 60% of the cells, as indicated by a one-component,
pure-diffusion fit. The remaining 40% of cells appear unaffected by the drug.data could also be well fit by a two-component diffusion
model (Eq. 7) (Fig. 3 G).
Traditionally, in two-component fits, the slow fraction has
been interpreted as bound and the fast fraction as freely
diffusing with a diffusion constant equal to the diffusion
constant of that fraction (15–18). For VBP-B-ZIP, this
predicts an average bound fraction of 19% and an average
free-diffusion constant of 7.55 2.7 mm2/s. These estimates
are close to the corresponding predictions from the diffusion-
and-binding model fits (a bound fraction of 11% and a free-
diffusion constant of 6.7 5 2.4 mm2/s).
To testwhether two-component diffusion fitswould always
agree with diffusion-and-binding model fits, we used the
diffusion-and-binding model to generate autocorrelation
functions over the range of association and dissociation
rates measurable by FCS (as defined in Fig. 1 B). Then we
fit these curves with two-component diffusion models. The
A
B
C
FIGURE 2 FCS and FRAP experiments yield consistent estimates for the
diffusion constant of unconjugated eGFP in NIH-3T3 cells. (A) Confocal
image of an NIH-3T3 nucleus. Scale bar, 5 mm. (B) The FCS autocorrelation
function (gray circles) is well described by a pure-diffusion model (black
line, Df ¼ 19 mm2/s). (C) The experimental FRAP recovery curve (gray
circles, Df ¼ 24 mm2/s) is also well modeled by a pure-diffusion fit (black
line). The estimated parameters listed here and in subsequent figure captions
correspond to the curves shown, and so are from single-spot data. The aver-
ages from many such fits with standard deviations are reported in Table 2.Biophysical Journal 97(1) 337–346
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FIGURE 3 (A) The presence of aDNA
binding domain in VBP-B-ZIP requires
a binding term in the FCS model. VBP-
B-ZIP contains a DNA binding domain
and a leucine zipper region, whereas
VBP-L-ZIP contains only the leucine
zipper. (B and C) These eGFP-tagged
constructs are transfected into NIH-3T3
cells (VBP-L-ZIP-GFP (B) and VBP-
B-ZIP-GFP (C)). Note that the DNA
binding domain leads to nuclear localiza-
tion inC compared toB. Scale bars, 5mm.
(D and E) The FCS autocorrelation
curves obtained for VBP-L-ZIP are well
described by a pure-diffusion model
(black line, Df ¼ 8.3 mm2/s), but those
for VBP-B-ZIP are not (E). Arrows in E
indicate discrepancies between the fit and
the VBP-B-ZIP data, with the residuals
plot shown below. (F) The full diffusion-
and-bindingmodel provides a better fit to
the VBP-B-ZIP data (Df ¼ 6.4 mm2/s,
kon ¼ 3 s1, koff ¼ 22 s1), confirmed
by a sixfold decrease in c2v (c
2
v ¼ 2:2
for pure-diffusion fit versus c2v ¼ 0.36
for the full-model fit). Plots of residuals
also reveal a consistent pattern of over-
shoot or undershoot in E (arrows), but
only random fluctuations in D or F. (G)
A two-component diffusion fit also
yields a good fit to the VBP-B-ZIP FCS
data, with estimates for this cell of
D1 ¼ 8.6 mm2/s, D2 ¼ 0.9 mm2/s, and
a fast fraction of r ¼ 0.72.two-component fit and/or its predictions became progres-
sively worse as the fraction of bound molecules increased,
with errors in estimated parameters increasing to >100%
(Fig. S3, A–E).
In sum, our comparisons of the diffusion-and-binding
model to the two-component diffusion model demonstrate
that in many cases the latter model would not be able to fit
data reflecting diffusion and binding. In those cases where
the two-component diffusion model could fit diffusion and
binding data, only a subset of fits would yield reasonably
accurate estimates for the free-diffusion constant and
bound fraction (VBP-B-ZIP is an example of such a case).
However, even in these optimal cases, the two-component
model cannot provide estimates of the association and disso-
ciation rates.
Comparison of FCS and FRAP measurements
To check our FCS measurements, we also performed FRAP
on VBP-B-ZIP and VBP-L-ZIP. Consistent with FCS,
single-cell FRAP data for VBP-L-ZIP (which should not
bind to DNA) were well fit by a pure-diffusion model
(Fig. 4 A). The average estimated diffusion constant was
nearly identical to that obtained from FCS (Table 2).
A diffusion model also yielded a good fit to the FRAP data
for VBP-B-ZIP (Fig. 4 B), but now the average predictedBiophysical Journal 97(1) 337–346diffusion constant was slower than that predicted by FCS.
This slower diffusion constant is explicable as effective
diffusion. Using the FCS estimates for the diffusion constant
and the association and dissociation rates, the equation for
the effective-diffusion constant in Table 1 predicts that
Deff¼ 5.85 2.6 mm2/s for VBP-B-ZIP, similar to the 4.45
1.4 mm2/s measured by FRAP. Thus, the FRAP and FCS
estimates appear to be consistent for VBP-B-ZIP.
To understand why FRAP yields only an effective-diffu-
sion constant for VBP-B-ZIP, whereas FCS provides an
independent estimate for the free-diffusion constant and the
association and dissociation rates, we computed the regime
spaces for the FRAP and FCS experiments. As expected,
we found that the point (kon; koff ) corresponding to the VBP-
B-ZIP association and dissociation rates measured by FCS
lay in the reaction-dominant regime for FCS (Fig. S4 A),
consistent with the reaction-dominant FCS fit that yielded
independent estimates for these parameters. The same
(kon; koff ) point, however, lay in the effective-diffusion regime
for FRAP (Fig. S4 B), consistent with the effective-diffusion
fit of the FRAP data.
This shift in the regime spaces between FCS and FRAP
cannot be explained by the faster acquisition rate of FCS
experiments. When we simulated FCS curves with a much
slower acquisition rate (10 ms, see Fig. S4 C), we obtained
only a minor shift in the regime space.
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spaces can be explained by the difference in spot size between
the FCS illumination volume and the FRAP photobleach.
When we simulated an identical spot size for the two proce-
dures, we obtained nearly identical regime spaces for each
(Fig. S4, D and E). This shows that the smaller spot size in
FCS is responsible for its ability to independently estimate
the association and dissociation rates of VBP-B-ZIP.
Application of the diffusion-and-binding model
to assay a small-molecule inhibitor of VBP-B-ZIP
DNA binding
Anantimony-containingwater-soluble compoundNSC13746
has been developed that binds to the basic region of VBP-
B-ZIP and inhibits its binding to DNA in vitro (30). This
molecule has potential therapeutic use in cancers that
A
B
FIGURE 4 FRAP experiments on VBP proteins. (A) VBP-L-ZIP experi-
mental FRAP curves (gray circles) are well described by a pure-diffusion fit
(black line), yielding for this cell Df ¼ 20.8 mm2/s. (B) VBP-B-ZIP experi-
mental FRAP curves are also well fit by a diffusion model (black line),
although here, the estimated diffusion coefficient (Deff ¼ 6.1 mm2/s) most
likely reflects effective diffusion. Please note that the incomplete recoveries
do not correspond to an immobile fraction but rather reflect the loss of fluo-
rescence due to photobleaching within a finite nucleus, which is accounted
for in the FRAP model (25).involve promiscuously activated forms of leucine zipper
transcription factors. To test the efficacy of NSC13746 in
live cells, we incubated cells with a concentration of the
drug 10 times higher than the concentration used in vitro,
and then used FCS to measure the effects on DNA binding
of VBP-B-ZIP (30).
Twodistinct populations of drug-treated cellswere detected
by FCS. In 60% of the cells the drug dramatically inhibited
DNA binding of VBP-B-ZIP, as indicated by a one-compo-
nent diffusion fit to the FCS data (Fig. 5 A) yielding an
estimated diffusion constant that was within the error of the
estimated diffusion constant of VBP-B-ZIP in untreated cells
(Table 2). In the remaining 40% of cells, the drug appeared to
have little effect on DNA binding of VBP-B-ZIP, as indicated
by a diffusion-and-bindingmodel fit to the FCS data (Fig. 5B)
that yielded estimates for the association and dissociation rates
statistically indistinguishable from those obtained for control
cells not treated with the drug (Table 2).
As a control, the drug was also tested on cells transfected
with the VBP-L-ZIP construct, which lacks the DNA binding
domain. The FCS data from all of these drug-treated VBP-L-
ZIP cells were fit in the same way (Fig. S5), namely with
a one-component diffusion fit that predicted a diffusion
constant statistically indistinguishable from that estimated
in untreated VBP-L-ZIP cells (Table 2). Thus, the drug
appeared to have no effect on VBP-L-ZIP, indicating that
its effects on VBP-B-ZIP were specific for the VBP-B-ZIP
DNA binding domain. In sum, our data suggest that the
compound NSC13746 can inhibit binding of VBP-B-ZIP to
DNA in live cells, but only in some cells.
DISCUSSION
A diffusion-and-binding model for FCS
We have developed and analyzed a model that can be used to
fit FCS data for a diffusing molecule that also binds to an
immobile substrate. We presumed that the concentration of
free binding sites is large relative to the concentration of
free, fluorescently-labeled molecules, a condition that is
likely to hold for transcription factors binding to the large
number of nonspecific sites spread throughout the nucleus.
When fit to experimental autocorrelation data, the model
can yield independent estimates for the molecule’s diffusion
constant and its association and dissociation rates of binding.
We showed that in theory, these three parameters can often be
estimated independently under typical conditions for live-cell
analysis, namely, with autocorrelation functions that decay on
a timescale of seconds or less. However, the theory shows that
in two cases, notably for molecules with fast association rates,
reliable estimates are only available for either one parameter
(an effective-diffusion constant that depends on the free-
diffusion constant and the association and dissociation rates)
or two parameters (the dissociation rate and the ratio of the
diffusion constant to the association rate). An awareness ofBiophysical Journal 97(1) 337–346
344 Michelman-Ribeiro et al.these limitations in parameter estimation is important when
applying such models to experimental data.
We tested the diffusion-and-binding model using a simple
and well-defined system based on the dimerization and DNA
binding domains from the transcription factor VBP. One
molecule that we tested, VBP-L-ZIP, contained only the
dimerization domain but no DNA binding domain and
accordingly was well fit by a pure-diffusion model yielding
A
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FIGURE 5 FCS detects a differential effect on DNA binding in the pres-
ence of an inhibitor. Cells containing transfected VBP-B-ZIP were incubated
with 100 mM of the inhibitor NSC13746 for ~2 h, after which FCS was per-
formed. Approximately 60% of the cells containing VBP-B-ZIP produced
FCS data that were well fit by a pure-diffusion model, yielding an estimated
diffusion constant that was statistically indistinguishable from that estimated
for freely diffusing VBP-B-ZIP (Table 2). (The fit in A yielded Df ¼ 4.4
mm2/s). F-tests on these data confirmed that no statistically relevant improve-
ment was achieved when using the diffusion-and-binding model. Thus, in
this population of cells, the inhibitor appeared to significantly inhibit
DNA binding. In contrast, 40% of the cells containing VBP-B-ZIP produced
FCS data that were well fit by only the diffusion-and-binding model. The
average estimated parameters from this subpopulation were indistinguish-
able from those obtained for untreated cells (Table 2). (The fit in B yielded
Df¼ 6.7 mm2/s, kon ¼ 2 s1, koff¼ 15 s1). Thus, in these cells, the inhibitor
had no apparent effect on DNA binding.Biophysical Journal 97(1) 337–346a diffusion constant consistent with the size of VBP-L-ZIP.
The second molecule that we tested, VBP-B-ZIP, contained
both the dimerization domain and the DNA binding domain
and accordingly was no longer fit by a pure-diffusion model
but instead required the full diffusion-and-binding model.
The predicted diffusion constant for VBP-B-ZIP was consis-
tent with its size, and the predicted binding rates suggested
transient interactions with chromatin. These results show
that binding behavior alters FCS data in a predictable way
that can be accounted for by the diffusion-and-bindingmodel.
We also compared this model to the traditional approach in
FCS binding analysis, which has been based on a two-compo-
nent diffusion fit. For VBP-B-ZIP, both the two-component
diffusion model and the diffusion-and-binding model yielded
similar estimates for the free-diffusion constant and the frac-
tion ofmolecules bound. However, the diffusion-and-binding
model had an advantage, because it also provided estimates of
the association and dissociation rates of binding.
By considering a wide range of binding rates, we showed
that agreement between the two models was not guaranteed.
We found that for data corresponding to diffusion and
binding events, the two-component diffusion fit could often
yield inaccurate estimates or no fit whatsoever. Thus, in these
cases, application of the two-component diffusion model
would lead either to erroneous results in the estimates for
free-diffusion constants and bound fractions or to the conclu-
sion that other models, such as anomalous diffusion, would
better describe the data.
In sum, compared to the widely used two-component
diffusion model, the diffusion-and-binding model has
a number of advantages for the analysis of binding interac-
tions with immobile substrates. For such cases, our new
model better reflects the underlying dynamics and so has
the potential to provide more information and improved
accuracy than two-component diffusion fits. These favorable
features suggest that the diffusion-and-binding model will be
useful in analyzing FCS data in other cases where diffusion
and binding are suspected of playing a role.
Comparison of FCS and FRAP
Although both FCS and FRAP have the potential to provide
estimates of in vivo binding rates, there have been only
a few direct comparisons of these two distinct approaches
(16,32,33). Our analysis shows that the two procedures yield
good agreement for the VBP-L-ZIP and VBP-B-ZIP frag-
ments. For VBP-L-ZIP, both approaches produced identical
estimates for the diffusion constant. For VBP-B-ZIP, there
was also consistency: FRAP yielded an effective-diffusion
constant that was expected based on the FCS estimates for
the VBP-B-ZIP diffusion constant and its association and
dissociation rates.
It is interesting to note that for the binding characteristics of
VBP-B-ZIP, FCS had an advantage over FRAP because it
provided independent estimates of three parameters: the
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tion rate. As we have shown, this was caused by the smaller
spot size of FCS, which resulted in the VBP-B-ZIP associa-
tion and dissociation rates lying within the full-model regime,
where independent estimates of all three parameters could
reliably be made. In contrast, the larger spot size of FRAP
placed the VBP-B-ZIP binding rates within the effective-
diffusion regime, thereby restricting the FRAP estimates to
just one parameter.
In principle, this limitation in FRAP could be overcome by
bleaching small, diffraction-limited spots. However, current
FRAP models for diffusion and binding are applicable only
to larger bleach spots, because these produce a more cylin-
drical 3D bleach pattern (4). Smaller bleach spots have a
complicated 3D profile and would introduce axial depen-
dence into the FRAP model (34).
Thus, FCS is preferable in the analysis of molecules with
fast association rates.On the other hand,moleculeswith tighter
binding that gives rise to longer residence times, would be
difficult to measure by FCS due to either drift of the specimen
or photobleaching (27,35). If we assume that a typical fluores-
cent molecule emits a few thousand photons before bleaching,
then a rough calculation suggests an upper bound of ~1 s on
residence times measurable by FCS given typical illumination
intensities. Thus, FRAP and FCS will likely provide comple-
mentary approaches to measure in vivo binding, but when
possible, the application of both, as we have done here, may
lend more confidence to the estimates obtained by either
approach alone.
It is important to emphasize that although the quantitative
consistency between the FRAP and FCS estimates is encour-
aging, the estimates are only as accurate as the underlying
model. One strength of our current analysis is that we have
used a model for FRAP and FCS that corresponds to the
known in vitro properties of the VBP dimerization and
binding domains. However, both the FRAP and FCS models
presume simple Fickian diffusion and single-step bimolecular
binding reactions. Thus, the current estimates may improve if
future tests demonstrate that these or other assumptions are
significant oversimplifications.
An in vivo assay of drug efﬁcacy
We used the diffusion-and-binding model to investigate the
effects of the drug NSC13746 on VBP-B-ZIP binding to
DNA. This compound binds to the basic region of all
VBP-B-ZIP transcription factors (30). This inhibits DNA
binding in vitro.
Notably, our in vivo analysis by FCS revealed a differen-
tial effect of the drug across the cell population: ~40% of the
cells showed no effects on DNA binding in the presence of
100 mM NSC13746, whereas the remaining ~60% of the
cells appeared to exhibit a dramatic reduction in DNA
binding. Note that the drug concentration used was 10 times
higher than that which inhibited DNA binding in vitro (30).The differential effect observed in vivo might arise due to
differential uptake or degradation of the drug in different cells,
or differential modification of the VBP-B-ZIP peptide such
that the drug binds poorly to VBP-B-ZIP in a subset of cells.
These various hypotheses should now be investigated. Under-
standing how such a differential effect might arise, and then
overcoming it, is important for drugs like NSC13746 that
might be used therapeutically. Mosaic responses can have
important clinical consequences, since single cells that survive
a treatment regimen may lead to relapse. Techniques that can
detect and quantify these mosaic responses are intrinsically
more useful than those that can only average the response
over a cell population. Thus, the FCS analysis we have devel-
oped here may provide a useful tool for testing other drugs to
assay their effects on binding in single, living cells.
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